INTRODUCTION
Squamous cell carcinoma (SCC) accounts for 94% of all oral malignancies with an annual incidence rate of 5 per 100,000 in the United States (Neville et al., 2008) . The main objective of the surgical treatment of oral squamous cell carcinoma (OSCC) is complete removal of the tumor (Sutton et al., 2003) .Despite advances in OSCC treatment, survival rates of patients have not been improved significantly due to local or regional lymph node recurrence (van Houten et al., 2004; . Even when the surgical margins are histopathologically diagnosed as tumor-free, approximately 30% of OSCC patients develop local recurrences . It is likely that genetically altered cells may be left in the histopathologically normal surgical margins and cause local recurrence. Therefore, it is important to evaluate not only histology but also the molecular nature of the surgical margin, targeting important genes in carcinogenesis Jelovac et al., 2009) . Epidermal growth factor receptor (EGFR) is an oncogene and it's over expression is identified in many malignancies, including breast, prostate, lung, bladder, and head and neck cancers (Oliveira et al., 2006) . In OSCC, EGFR over expression is related to decreased overall survival, metastases to lymph nodes and diffuse tumor invasion (Oliveira et al., 2006; Laimer et al., 2007) . The aim of the present study was to investigate the presence of EGFR gene in histopathologically tumor-free margins.
MATERIALS AND METHODS

Patients and inclusion criteria
A total of 40 paraffin-embedded tissue blocks from OSCC cases were obtained from the Pathology Department of Dental School, Tabriz, Iran. All the samples included histologically tumor-free margins and were reviewed by two pathologists. Surgical margin was considered negative when the distance from the tumor to resection surface was 5 mm or more . Inclusion criteria were patients with complete records, negative surgical margins and no history of radiotherapy, chemotherapy and recurring tumors. Tumor tissue and adjacent normal surgical margins were analyzed for EGFR expression.
Immunohistochemistry
One 4-µm-thick section from each paraffin-embedded block was cut and deparaffinized at 37°C for 24 h. The slides were rehydrated through graded concentrations of alcohol to retrieve surface antigens. Then, they were put in a microwave oven in boiling citrate buffer (pH = 6) for 5 min and floated in phosphate-buffered saline (PBS) (pH = 6). Then, immunohistochemical staining steps were followed sequentially: Blocking the endogenous peroxides activity by 11.11% hydrogen peroxide for 5 min; immersion in PBS; use of the monoclonal antibody of EGFR (Dako, Denmark A/S; Lot no: 00049086) for 30 min; immersion in PBS; and use of the envision solution for 15 min. Finally, the samples were stained with hematoxylin and eosin and studied at high magnification (40x) under a light microscope. The proportion score described the estimated fraction of positively stained tumor cells (1 <10%; 2 = 10 to 50%; 3 = 50 to 80%; 4 ≥80%). The intensity score represented the estimated staining intensity (1, no staining; 2, weak; 3, moderate; 4, strong) (Kusukawa et al., 1996) .
Statistical analysis
Statistical analysis was carried out in an attempt to determine EGFR expression in the tumor tissue and adjacent normal surgical margins, using Fisher exact test. Statistical significance was defined at p<0.05.
RESULTS
Clinical data
Complete records and tissue specimens from 40 cases of OSCC (16 females and 24 males) were available. The median age of the patients was 26 (a range of 33 to 98 years). The most common site was the tongue which accounted for 42.5% of the cases. The remaining tumors were found in the lower lip (37.5%), palate (10%), mandible (5%), floor of the mouth (2.5%) and buccal mucosa (2.5%) ( Table 1) . A total of 95% of the tumors were well differentiated, with 5% moderately differentiated.
EGFR expression
Strong EGFR staining was seen in the membrane of tumor cells in 30 of 40 (75%) tumor tissues ( Figure 1 ) and 4 of 40 (10%) histopathologic tumor-free margins ( Figure  2 ). On the other hand, 10% of histopathologic tumor-free margins were stained with EGFR. However, significant difference was found in the EGFR staining between the tumor tissue and histopathologic tumor-free margins (p = 0.01). No significant differences were found between genders.
DISCUSSION
SCC is the most common oral cancer which originates from the dysplastic surface epithelium and is composed of islands of malignant squamous epithelial cells that have invaded the underlying connective tissue (Neville et al., 2008) . Approximately, 40% treatment failure rate is seen in patients with OSCC, the most common cause of which is recurrence in the local or regional lymph nodes Hansen et al., 1998) . Various research studies have reported recurrence in spite of having tumor-free surgical margins. In two studies conducted by , even when the surgical margin was diagnosed as tumor-free, a 30% recurrence rate was reported. In another similar study, Jelovac et al. (2009) reported a 10 to 30% recurrence rate. Molecular changes that might indicate early tumor development are seen in normal surgical margins of tumors in oropharynx and larynx areas (California et al., 1996; Tabor et al., 2001) .
EGFR, a receptor tyrosine kinase of ErbB family, can be hyperactive in a normal cell and provides signals for cellular proliferation, anti-apoptosis, angiogenesis and metastasis, which are the main characteristics of cancer (Sebastian et al., 2006) . This receptor is abnormally activated in many epithelial tumors (Mendelson et al., 2006) . In OSCC, this oncogene is associated with tumor invasion, increased metastasis to cervical lymph nodes and lower histological differentiation of the tumor (Oliveira et al., 2006) . EGFR overexpression and lower diseasefree survival were described by Grandis et al. (1998) . In our study, EGFR overexpression was observed in 75% of tumor tissues. Other studies, such as Laimer et al. (2007) (73.42%) and Ryott et al. (2009) (72%) , confirm EGFR overexpression in our study. In addition to tumor tissues, EGFR overexpression was observed in 10% of the histopathologically normal margins. In several studies, different markers have been investigated in histologically tumor-free margins and similar results have been reported. Jelovac et al. (2009) found p53 mutations and ErbB2 and c-Myc amplifications in tumor-free surgical et al. (2009) found p53 and p16 expression in tumor-free surgical margins. One study showed that EGFR/SGLT1 coexpression may contribute to the growth and survival of OSCC (Hanabata, 2011) . EGFR has been reported as an important target for cancer therapy and different types of EGFR inhibitors have been used in the treatment of various cancers, including gastric cancer, colorectal and lung cancers with EGFR overexpression (Hiraishi et al., 2008; Becker et al., 2006; Moroni et al., 2005) . Hiraishi et al. (2008) have reported that EGFR inhibitor in combination with Cisplatin, a chemotherapy drug, is a useful strategy for treatment of patients with OSCC. Although, the expression of EGFR in tumor cells and marginal cells had significant difference, however the expression of EGFR in some marginal cells that seem normal in H&E staining depicted the presence of tumor cells in these margins. Therefore, our result supports the importance of using EGFR staining technique. A new technique such as dual 1.5 mm core tissue microarray is a valid, rapid, economical and tissue-saving way to study OSCC biopsies (Monteiro et al., 2010) . However, prognostic relevance is debatable and requires further standardization (Oliveira and Ribeiro-Silva, 2011) .
In conclusion, assessment of tumor-free surgical margins by conventional histopathologic examination is not sufficient and detection of some oncogenes like EGFR may identify patients who are at a high risk of tumor recurrence and can benefit from anti-EGFR treatments.
